PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Filippo Gustavo Dall’Olio, Francesco Gelsomino, Nicole Conci, Laura Marcolin, Andrea De Giglio, Giada Grilli, Francesca Sperandi, Francesca Fontana, Mario Terracciano, Benedetta Fragomeno, Nastassja Tober, Giulia Manferrari, Stefano Brocchi, Rita Golfieri, Michelangelo Fiorentino, Andrea Ardizzoni
Topics & Concepts
MedicineCirculating tumor cellHazard ratioLung cancerOncologyInternal medicineCancerBiomarkerClinical endpointProspective cohort studyConfidence intervalMetastasisClinical trialBiochemistryChemistryCancer Cells and MetastasisCancer Immunotherapy and BiomarkersLung Cancer Research Studies